Rocket Pharmaceuticals Q2 EPS USD 1.08
RCKT•Quarterly net income
Aug. 10 (Reuters) - Rocket Pharmaceuticals Q2 net income USD 123.2 million.
Related News
Marcus & Millichap’s IPA Capital Markets arranges $75.1 million Monroe Hotel recapitalization in Miami Beach
MMI•
ASP Isotopes COO Robert Ainscow sells 25,000 shares for $97,625
ASPI•
NASDAQ Trade Halt Continues CTSO.O Halt News Pending at 03:28 AM
CTSO•
Evolus CEO David Moatazedi disposes of 105,108 common shares for $950,974.76
EOLS•
Rocket Lab CFO Adam C. Spice disposes of 140,157 shares valued at $8.79 million
RKLB•